Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2000
09/28/2000WO2000056352A2 Reagents and methods useful for detecting diseases of the prostate
09/28/2000WO2000056351A2 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
09/28/2000WO2000056350A2 Methods of use of beta 1-integrin inhibitors
09/28/2000WO2000056349A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000WO2000056345A2 Methods for limiting scar and adhesion formation
09/28/2000WO2000056327A1 Ascorbic acid composition and method for treatment of aging or damaged skin
09/28/2000WO2000056291A1 Pharmaceutical solubilized in aerosol propellant
09/28/2000WO2000056290A1 Transdermal therapy system and method for producing the same
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000056158A1 Composition and methods for the treatment of cancer and viral infections
09/28/2000WO2000056144A1 Human sperm surface antigen
09/28/2000WO2000042973A3 Homing pro-apoptotic conjugates and methods of using same
09/28/2000WO2000042972A3 Compositions and methods for intraductal gene therapy
09/28/2000WO2000041740A3 Particles for oral delivery of peptides and proteins
09/28/2000WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
09/28/2000WO2000040693A3 Expression of secreted human alpha-fetoprotein in transgenic animals
09/28/2000WO2000027875A8 Activity dependent neurotrophic factor iii (adnf iii)
09/28/2000WO2000027424B1 Upregulation of endogenous prostaglandins to lower intraocular pressure
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000021559A3 Blocking factor b to treat complement-mediated immune disease
09/28/2000WO2000020576A3 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000018796A3 Secretory protein- zsig48
09/28/2000WO2000016808A3 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000012118A9 Inhibiting cardiomyocyte death
09/28/2000WO2000009085A3 Oral formulation containing cyclosporin
09/28/2000DE19939070A1 Use of nucleic acid encoding Leishmania kinases for identifying and preparing diagnostic, preventative and therapeutic agents
09/28/2000DE19912477A1 Self-adhesive transdermal therapeutic system for e.g. drug or hormone delivery, comprises an active agent deposit and a connected matrix, including a paper substrate
09/28/2000DE19912439A1 Use of yeast-derived killer toxins to treat or prevent diarrhea, particularly in piglets and especially where caused by Escherichia coli
09/28/2000DE19911992A1 RNA Polymerase I Transkriptionsfaktor TIF-IA RNA polymerase I transcription factor TIF-IA
09/28/2000DE19911771A1 Neue LHRH-Antagonisten mit verbesserten Löslichkeitseigenschaften New LHRH antagonists with improved solubility
09/28/2000CA2855415A1 Phenylalanine derivatives
09/28/2000CA2512479A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2512291A1 Pro4356 polypeptides and nucleic acids encoding the same
09/28/2000CA2510982A1 Lectin-like protein, pro1890, encoding nucleic acids, pro1890 antibodies and uses thereof
09/28/2000CA2510931A1 Pro4334 polypeptides and nucleic acids
09/28/2000CA2510806A1 Screted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2442340A1 Methods for limiting scar and adhesion formation
09/28/2000CA2377383A1 Apoptosis related genes
09/28/2000CA2368916A1 49 human secreted proteins
09/28/2000CA2368733A1 Phenylalanine derivatives
09/28/2000CA2368672A1 Genomic sequence of the purh gene and purh-related biallelic markers
09/28/2000CA2368548A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367475A1 Hybrid synthetase, hybrid peptide and composition containing same
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367282A1 Pharmaceutical compositions comprising metal complexes
09/28/2000CA2367125A1 Reagents and methods useful for detecting diseases of the prostate
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/28/2000CA2367048A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000CA2367025A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366613A1 Particle based vaccine composition
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2366267A1 49 human secreted proteins
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2366080A1 Prediction of diabetes impaired wound healing by urinary nitrate assay
09/28/2000CA2365405A1 Human tumor necrosis factor receptor-like 2
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365121A1 Antibodies specific for cyp1b1
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038967A2 Virus with modified binding moiety specific for the target cells
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038960A1 BSMAP, a surface protein expressed specifically in the brain
09/27/2000EP1038957A1 Tsa305 gene
09/27/2000EP1038864A1 Novel metalloproteinase inhibitors
09/27/2000EP1038574A2 Method and apparatus for preparing dispersions containing active substances
09/27/2000EP1038532A1 Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive
09/27/2000EP1038530A2 Immunomodulator comprising DNA
09/27/2000EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis
09/27/2000EP1038025A1 Genetic alterations associated with cancer
09/27/2000EP1038020A1 Secreted protein nsl4
09/27/2000EP1038019A1 NOVEL ribB
09/27/2000EP1038015A2 Mood disorder gene
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1038006A1 Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis
09/27/2000EP1038003A1 Cyclic gmp phosphodiesterase
09/27/2000EP1038002A1 Ubiquitin-like conjugating protein
09/27/2000EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection
09/27/2000EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides
09/27/2000EP1037998A1 guaA POLYPEPTIDES
09/27/2000EP1037995A1 Human interferon-epsilon: a type 1 interferon
09/27/2000EP1037994A1 Peptide antagonists of vascular endothelial growth factor
09/27/2000EP1037993A2 A new gene called oligophrenin 1, its expression product, and the diagnostic and therapeutic applications thereof
09/27/2000EP1037992A1 P53 regulatory protein called rb18a and uses thereof
09/27/2000EP1037991A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
1 ... 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 ... 3163